$1.81 Bn Optical Genome Mapping Market Global Forecasts 2024-2034 by Product and Services, Technique, Application, and End-User
23 janv. 2025 04h28 HE
|
Research and Markets
Dublin, Jan. 23, 2025 (GLOBE NEWSWIRE) -- The "Optical Genome Mapping Market by Product & Service, by Technique, by Application, by End-User, and By Region" report has been added to ...
Genetic Toxicology Testing Market Research 2024-2034: Increased R&D Activities, Strategic Collaborations, and a Focus on Personalized Therapy Boosts Growth
23 janv. 2025 04h05 HE
|
Research and Markets
Dublin, Jan. 23, 2025 (GLOBE NEWSWIRE) -- The "Genetic Toxicology Testing Market by Product, by Type, by Assay, by End-User, and By Region" report has been added to ResearchAndMarkets.com's...
Genotyping Market Size is Expected to Reach USD 70.85 Billion by 2033, Growing at a CAGR of 14.32%: Straits Research
22 janv. 2025 10h20 HE
|
Straits Research Private Limited - Garner Insights
New York, United States, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Genotyping involves analyzing DNA sequences to ascertain the genetic makeup of the genotypes of living things, such as people, plants,...
Fusion Biopsy Market to hit USD 2.1 billion by 2034, says Global Market Insights Inc.
22 janv. 2025 07h03 HE
|
Global Market Insights Inc.
Selbyville, Delaware, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Fusion biopsy market size was valued at USD 829.1 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 9.9%...
Precision Medicine Collaboration and Licensing Deals 2019-2024
16 janv. 2025 06h03 HE
|
Research and Markets
Dublin, Jan. 16, 2025 (GLOBE NEWSWIRE) -- The "Precision Medicine Collaboration and Licensing Deals 2019-2024" report has been added to ResearchAndMarkets.com's offering. This report contains a...
Silexion Therapeutics Announces Pricing of $5.0 Million Public Offering
15 janv. 2025 20h00 HE
|
Silexion Therapeutics Corp
Cayman Islands, January 15, 2025 -- Silexion Therapeutics Corp (NASDAQ: SLXN) (“Silexion Therapeutics” or the “Company”), a clinical-stage biotech developing RNA interference (RNAi) therapies for...
Silexion Therapeutics Announces Additional Promising Preclinical Data for SIL-204, Demonstrating Impressive Synergy with First-Line Pancreatic Cancer Chemotherapies
15 janv. 2025 16h01 HE
|
Silexion Therapeutics Corp
Cayman Islands, January 15, 2025 – Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotech developing RNA interference (RNAi) therapies for KRAS-driven...
Neurogenomics Market Forecast and Trends Analysis to 2031: Healthcare Investments and Early Detection Drive Robust Uptake of Neurogenomics Solutions
15 janv. 2025 07h00 HE
|
Research and Markets
Dublin, Jan. 15, 2025 (GLOBE NEWSWIRE) -- The "Neurogenomics Market Size, Share, Forecast, & Trends Analysis by Offering Application End User - Global Forecast to 2031" report has been added to ...
Pharmacovigilance Outsourcing Market Outlook 2024-2028, Featuring a Competitive Landscape for Major and Innovative Companies
14 janv. 2025 11h21 HE
|
Research and Markets
Dublin, Jan. 14, 2025 (GLOBE NEWSWIRE) -- The "Pharmacovigilance Outsourcing Market Report 2024" has been added to ResearchAndMarkets.com's offering.The pharmacovigilance outsourcing market size is...
Proscia’s Growth More Than Doubles As Customers Adopt Enterprise Pathology
13 janv. 2025 08h00 HE
|
Proscia
Record year comes as the rise of precision medicine drives a surge in demand